Metastasectomy for stage IV melanoma: For whom and how much?

Surgical Oncology Clinics of North America

Volumn 20, Issue 1, 2011, Pages 133-144

  Caudle, Abigail S ^a   Ross, Merrick I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Metastasis; Patient selection; Stage IV melanoma; Surgical management

Indexed keywords

DACARBAZINE; INTERLEUKIN 2;

ANATOMICAL VARIATION; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HUMAN; LAPAROTOMY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; METASTASECTOMY; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGNOSIS; REVIEW; SKIN METASTASIS; SOFT TISSUE METASTASIS; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; SURVIVAL TIME; SYSTEMIC THERAPY; THORACOTOMY; TREATMENT RESPONSE; TUMOR BIOPSY; VISCERAL METASTASIS;

DECISION MAKING; DISEASE PROGRESSION; HUMANS; LUNG NEOPLASMS; MELANOMA; NEOPLASM METASTASIS; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS;

EID: 78649461907     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.09.010     Document Type: Review

References (40)

1. Middleton M., Grob J., Aaronson N., et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000, 18:158-166.
2. Atkins M., Lotze M., Dutcher J., et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 1999, 17:2105-2116.
3. Hsueh E., Essner R., Foshag L., et al. Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol 2002, 20:4549-4554.
4. Morton D. An international, randomized, double-blind, phase 3 study of the specific active immunotherapy agent, onamelatucel-L (Canvaxin), compared to placebo as a postsurgical adjuvant in AJCC stage IV melanoma 2006, Society of Surgical Oncology, San Diego.
5. Sondak V., Liu P., Warneke J., et al. Surgical resection for stage IV melanoma: a Southwest Oncology Group trial (S9430). J Clin Oncol 2006, 24:8019.
6. Essner R., Lee J., Wanek L., et al. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004, 139:961-966.
7. Collins C. PET/CT in oncology: for which tumours is it the reference standard?. Cancer Imaging 2007, 7:S77-S87.
8. Harpole D., Johnson C., Wolfe W., et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992, 103:743-748.
9. Leo F., Cagini L., Rocmans P., et al. Lung metastases from melanoma: when is surgical treatment warranted?. Br J Cancer 2000, 83:569-572.
10. Petersen R., Hanish S., Haney J., et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 2007, 133:104-110.
11. Ollila D., Stern S., Morton D. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J Surg Oncol 1998, 69:206-211.
12. Barth A., Wanek L., Morton D. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995, 181:193-201.
13. Balch C., Buzaid A., Soong S., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648.
14. Balch C., Gershenwald J., Soong S., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
15. Balch C., Soong S., Murad T., et al. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol 1983, 1:126-134.
16. Bowen G., Chang A., Lowe L., et al. Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification. Arch Dermatol 2000, 136:1397-1399.
17. Gadd M., Coit D. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch Surg 1992, 127:1412-1416.
18. Markowitz J., Cosimi L., Carey R., et al. Prognosis after initial recurrence of cutaneous melanoma. Arch Surg 1991, 126:703-707.
19. Neuman H., Patel A., Hanlon C., et al. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann Surg Oncol 2007, 14:2847-2853.
20. Patel J., Didolkar M., Pickren J., et al. Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg 1978, 135:807-810.
21. Ricaniadis N., Konstadoulakis M., Walsh D., et al. Gastrointestinal metastases from malignant melanoma. Surg Oncol 1995, 4:105-110.
22. Branum G., Seigler H. Role of surgical intervention in the management of intestinal metastases from malignant melanoma. Am J Surg 1991, 162:428-431.
23. Ollila D., Essner R., Wanek L., et al. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch Surg 1996, 131:979-980.
24. Agrawal S., Yao T., Coit D. Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol 1999, 6:336-344.
25. Rose D., Essner R., Hughes T., et al. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 2001, 136:950-955.
26. Pawlick T., Zorzi D., Abdalla E., et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 2006, 13:712-720.
27. Wood T., DiFronzo L., Rose D., et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?. Ann Surg Oncol 2001, 8:658-662.
28. Mittendorf lE., Lim S., Schacherer C., et al. Melanoma adrenal metastasis: natural history and surgical management. Am J Surg 2008, 195:368-369.
29. Collinson F., Lam T., Bruijn M., et al. Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Ann Surg Oncol 2008, 15:1741-1749.
30. de Wilt J., McCarthy W., Thompson J. Surgical treatment of splenic metastases in patients with melanoma. J Am Coll Surg 2003, 197:38-43.
31. Sampson J., Carter J., Friedman A., et al. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11-20.
32. Wronski M., Arbit E. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000, 93:9-18.
33. Oredsson S., Ingvar C., Stromblad L., et al. Palliative surgery for brain metastases of malignant melanoma. Eur J Surg Oncol 1990, 16:451-456.
34. Overett T., Shiu M. Surgical treatment of distant metastatic melanoma. Indications and results. Cancer 1985, 56:1222-1230.
35. Ollila D., Hsueh E., Stern S., et al. Metastasectomy for recurrent stage IV melanoma. J Surg Oncol 1999, 71:209-213.
36. Reintgen D., Thompson W., Garbutt J., et al. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery 1984, 95:635-639.
37. Gutman H., Hess K., Kokotsakis J., et al. Surgery for abdominal metastases of cutaneous melanoma. World J Surg 2001, 25:750-758.
38. Lavine S., Petrovich Z., Cohen-Gadol A., et al. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999, 44:59-64.
39. Andrews S, Robinson L, Cantor A, et al. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control 2006, 13:218-223.
40. Haigh PI, Essner R, Wardlaw JC, et al. Long-term survival after complete resection of melanoma metastatic to the adrenal gland. Ann Surg Oncol 1999, 6(7):633-639.